Precision Oncology

Precision oncology.
Making complex cancer data clearer through science.

Supporting oncologists, clinicians, and hospital cancer teams with independent molecular evidence review for more informed cancer care.

Precision oncology evidence is advancing faster than any one person can reasonably track. We bring biomarkers, treatment options, and the evidence behind them into a focused molecular and genomic review for clinicians and researchers.

Request a Molecular & Genomic Review
Precision oncology molecular data review
🔒Confidential Biology Review
🎓Molecular Oncology Expertise
🌍Clear Molecular Summary
⚡Clear Written Summary
About MPO

Independent molecular review for
more informed cancer care.

Monarch Precision Oncology was created to support oncologists, clinicians, and hospital cancer teams in navigating complex genomic, molecular, pathology, and treatment information.

MPO provides independent, evidence-based molecular review designed to complement clinical decision-making. Our role is to synthesize cancer biology, biomarkers, relevant therapeutic evidence, and clinical-trial opportunities into a focused scientific review for the treating team. Diagnosis and treatment decisions remain with the responsible clinicians.

Professional portrait of Tahereh Kashkoulinejad Kouhi, PhD
Professional Biography

Tahereh K. Kouh, PhD

Molecular Biology & Precision Oncology

Dr. Tahereh Kashkoulinejad Kouhi is a molecular biology scientist and precision oncology researcher with expertise in cancer genomics, molecular profiling, translational oncology, and evidence-based therapeutic assessment.

She is the developer of OncoAtlas, an interactive precision oncology platform covering 30 hematologic and solid malignancies. OncoAtlas integrates clinical guidelines, molecular biomarkers, targeted therapies, immunotherapies, and emerging clinical trial evidence into structured, cancer-specific resources designed for oncology professionals.

Her work focuses on bridging molecular discoveries and clinical oncology through rigorous scientific evidence synthesis and accessible knowledge platforms.

Read more

What MPO Biology Reviews

How MPO can help.

MPO supports oncology professionals through scientific interpretation, molecular evidence review, and clinically relevant synthesis.

Genomics
🧬

Molecular Report Interpretation

We review genomic, biomarker, pathology, and molecular-testing reports and explain their potential clinical relevance in clear language.

Treatment
💊

Treatment-Landscape Biology Review

We summarize evidence-based treatment concepts that may be relevant to the cancer type, stage, biomarkers, and prior therapies.

Clinical Evidence
🔬

Clinical Evidence Review

We synthesize biomarker-linked and treatment-relevant evidence to support focused review by the treating oncology team.

Clinical Trials
🗂️

Clinical Trial Matching Support

We identify clinical trials and investigational strategies with potential biological relevance and highlight key eligibility considerations for clinical review.

How It Works

Structured. Evidence-based.
Easy to follow.

A focused review process built around molecular findings, treatment history, and clinical questions.

💬
01

Share Reports

Provide relevant pathology, molecular testing, imaging summaries, treatment history, and clinical questions.

🔍
02

Biology Review

MPO evaluates biomarkers, pathways, resistance patterns, and evidence relevant to the available information.

🧠
03

Clear Summary

You receive an organized explanation of key findings, clinical-trial considerations, and discussion points.

🌱
04

Oncology Discussion

Use the review to support multidisciplinary discussion and clinician-led treatment planning.

Review Examples

Examples of questions MPO can clarify.

These examples show the types of scientific questions that can be addressed during a molecular review.

Genomics
What is the clinical relevance of this mutation, amplification, fusion, or biomarker in the context of the cancer type and treatment history?
🧬
Molecular interpretation
Genomic and biomarker reports
Evidence Review
Which treatment strategies are supported by the available molecular and clinical evidence in this disease context?
📚
Treatment-landscape review
Published evidence and clinical context
Clinical Trials
Which trials appear biologically relevant to this molecular profile, and which eligibility criteria require clinical assessment?
🗂️
Trial-matching support
Biomarker-informed trial search

Complex molecular findings?
Bring the evidence into focus.

MPO supports clinical teams with focused molecular and evidence review for precision oncology care.

Request a Molecular & Genomic Review
Get In Touch

Ready for a
molecular & genomic review?

For oncologists, clinicians, hospitals, and cancer care teams seeking focused review of genomic findings, molecular evidence, treatment context, or clinical-trial options. Every professional inquiry is treated confidentially.

Emailcontact@mpocare.com
Phone+1 (647) 594-1366

Request a Molecular & Genomic Review

🔒 Your information is confidential and used only to respond to your inquiry.

MPO provides interpretation and education, not medical diagnosis or treatment prescription.

Explore our science

Precision oncology evidence review topics

Focused scientific resources for oncology teams exploring genomic profiling, biomarker interpretation, evidence synthesis, molecular tumor board discussions, and clinical trials.

Precision Oncology Services Cancer Genomic Profiling Molecular Tumor Board Support Cancer Biomarker Interpretation Oncology Clinical Trial Matching